Amgen v. Regeneron: Everyone Wins?

The FDA approved Amgen’s (AMGN) Repatha today, perhaps setting up an “epic battle” between it, and Regeneron (REGN) and Sanofi (SNY), who make a similar drug. Piper Jaffray’s Joshua Schimmer and team contend that “everybody wins.” They explain: Associated Press After the close, Amgen announced the approval of Repatha for LDL [the bad cholesterol, ed.] […]